Patient Shortage Hits Clinical Trials in India

If talent crunch was not enough, the pharmaceutical industry in India is facing another pressing issue — patient crunch. … This difficulty in recruiting and retaining patients lengthens the period by which the drugs can reach the market by a year or so, and increase costs of trials by billions of dollars.
Sify